Immunic (IMUX) Capital Expenditures (2013 - 2026)
Immunic (IMUX) reported Capital Expenditures of $2000.0 for Q1 2026, down 95.74% on a YoY basis from $47000.0 in Q1 2025, and down 81.82% sequentially from $11000.0 in Q4 2025.
Immunic (IMUX) Capital Expenditures (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Capital Expenditures data on file, last reported at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 95.74% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $116000.0 (down 58.57% YoY), and the FY2025 full-year result was $161000.0, down 39.02% from the prior year.
- Capital Expenditures fell to $2000.0 in Q1 2026, from $11000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $180000.0 in Q2 2024 to a low of -$1000.0 in Q4 2022.
- A 5-year average of $51352.9 and a median of $36000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures tumbled 105.26% in 2022 and surged 16600.0% in 2023, its largest moves.
- Tracing IMUX's Capital Expenditures over 5 years: stood at -$1000.0 in 2022, then surged by 16600.0% to $165000.0 in 2023, then sank by 98.18% to $3000.0 in 2024, then surged by 266.67% to $11000.0 in 2025, then tumbled by 81.82% to $2000.0 in 2026.
- Business Quant data shows IMUX's Capital Expenditures at $2000.0 in Q1 2026, $11000.0 in Q4 2025, and $67000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Dec 31, 2023 | 165,000.00 |